Search results
Results from the WOW.Com Content Network
Medicaid recipients in Wisconsin will have access to the first over-the-counter birth control pill starting Tuesday, allowing them to easily receive contraceptive medication with no out-of-pocket ...
Under the original conditions of BadgerCare, families could enroll if their net incomes were up to 185% of the federal poverty level (about $31,000 for a family of four in 2000) and could remain on BadgerCare as long as their incomes did not exceed 200% of the federal poverty level. [1]
A report by the Wisconsin Policy Forum explores what it would mean if Wisconsin expanded Medicaid coverage to more low-income adults. Wisconsin Policy Forum: Wisconsin could save $1.7 billion if ...
The Wisconsin Department of Health Services (WisDHS) is a governmental agency of the U.S. state of Wisconsin responsible for maintaining public health. It administers a wide range of services in the state and at state institutions, regulates hospitals and care providers, and supervises and consults with local public health agencies.
Among adults aged 18 to 64, states that expanded Medicaid had an uninsured rate of 7.3% in the first quarter of 2016, while non-expansion states had a 14.1% uninsured rate. [31] The Centers for Medicare and Medicaid Services (CMS) estimated that the cost of expansion was $6,366 per person for 2015, about 49 percent above previous estimates.
Medicare Savings Programs (MSPs), administered through the Medicaid program in each state, offer several opportunities to get coverage of Part A and Part B deductibles, coinsurance, and copayments.
In the US, where a system of quasi-private healthcare is in place, a formulary is a list of prescription drugs available to enrollees, and a tiered formulary provides financial incentives for patients to select lower-cost drugs. For example, under a 3-tier formulary, the first tier typically includes generic drugs with the lowest cost sharing ...
[6] This consolidation and concentration has led to lawsuits and bipartisan criticism for unfair business practices. [7] [8] In 2024, The New York Times, [9] Federal Trade Commission, [10] [11] and many states Attorneys General [12] [13] accused pharmacy benefit managers of unfairly raising prices on drugs.